"Liposarcoma, Myxoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A liposarcoma containing myxomatous tissue. (Dorland, 27th ed)
| Descriptor ID |
D018208
|
| MeSH Number(s) |
C04.557.450.550.420.425 C04.557.450.795.465.425
|
| Concept/Terms |
Liposarcoma, Myxoid- Liposarcoma, Myxoid
- Liposarcomas, Myxoid
- Myxoid Liposarcomas
- Myxoid Liposarcoma
|
Below are MeSH descriptors whose meaning is more general than "Liposarcoma, Myxoid".
Below are MeSH descriptors whose meaning is more specific than "Liposarcoma, Myxoid".
This graph shows the total number of publications written about "Liposarcoma, Myxoid" by people in this website by year, and whether "Liposarcoma, Myxoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 3 | 0 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liposarcoma, Myxoid" by people in Profiles.
-
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. Lancet. 2024 Apr 13; 403(10435):1460-1471.
-
Myxoid Liposarcomas: Systemic Treatment Options. Curr Treat Options Oncol. 2023 04; 24(4):274-291.
-
The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Mol Cell. 2022 05 05; 82(9):1737-1750.e8.
-
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy. J Immunother Cancer. 2021 05; 9(5).
-
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States. Cancer Med. 2020 07; 9(13):4593-4602.
-
Myxoid Liposarcoma With Skeletal Metastases: Pathophysiology and Imaging Characteristics. Curr Probl Diagn Radiol. 2021 Jan - Feb; 50(1):66-73.
-
Systemic Interferon-? Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial. Cancer Immunol Res. 2019 08; 7(8):1237-1243.
-
Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation. Lab Invest. 2016 08; 96(8):885-94.
-
Immunohistochemical expression of p16 in lipoblastomas. Hum Pathol. 2016 Jan; 47(1):64-9.
-
Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations. Cancer. 2013 May 15; 119(10):1868-77.